Changes of Skin Resistance After Midazolam and After the End of Anaesthesia
1 other identifier
interventional
28
1 country
1
Brief Summary
It has been described that sympathetic activity, measured as changes in electrical skin resistance (SR), may be used to assess the adequacy of general anaesthesia. Our prospective study investigated how far measurements of skin resistance can help determine level of sedation. The secondary aim was to investigate if changes in skin resistance can be used for assessing recovery from anaesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Oct 2014
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2015
CompletedFirst Submitted
Initial submission to the registry
September 17, 2018
CompletedFirst Posted
Study publicly available on registry
January 2, 2019
CompletedJanuary 3, 2019
December 1, 2018
9 months
September 17, 2018
December 31, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes of skin resistence (percent from base-line values measured in ohms) during sedation
Investigation how far measurements of skin resistance can help determine level of sedation induced by intravenous midazolam
10 min. before administration and 5 min. after administration of midazolam (total 15 min.)
Secondary Outcomes (1)
Changes of skin resistence (percent from base-line values and values before termination of inhalational agent administration measured in ohms) during recovery from anaesthesia
From termination of inhalational agent administration till recovery to verbal comunication (expected time max. 15 min)
Study Arms (2)
Midazolam
EXPERIMENTALMidazolam 2 mg was administered 5 min. after placebo and 5 min. before inducton to general anaesthesia IV.
Control
PLACEBO COMPARATORNormal saline 5 ml was administered 10 min. after insertion of intravenous cannula IV..
Interventions
Administering premedication with sedative drug to relieve anxiety
Eligibility Criteria
You may qualify if:
- adult patients scheduled for knee arthroscopy or minor plastic surgery under general anaesthesia
You may not qualify if:
- previous history of taking drugs affecting mental functions, history of psychic illness, implanted electrical device, know allergy to benzodiazepines, myasthenia gravis, ASA classification ASA 3 and more. All patients consented not to use any medication for sedation or anxiety, opioid analgesics, ethanol and illicit drugs 24 hours before surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Kralovske Vinohrady
Prague, 100 00, Czechia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiri Malek, M.D.
University Hospital Kralovske Vinohrady
- STUDY CHAIR
Alice Kurzova, M.D.
University Hospital Kralovske Vinohrady
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Placebo of the same volume and colour as active substance
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prfo. Jiri Malek, CSc.
Study Record Dates
First Submitted
September 17, 2018
First Posted
January 2, 2019
Study Start
October 1, 2014
Primary Completion
June 26, 2015
Study Completion
June 26, 2015
Last Updated
January 3, 2019
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share